Feb 12, 2026 08:02AM
Nov 20, 2025 04:04PM
Nov 18, 2025 04:30AM
Nov 13, 2025 01:11PM
Nov 13, 2025 06:27AM
Sep 29, 2025 09:00AM
Aug 25, 2025 06:35AM Lucid Capital Markets Starts Cue Biopharma (CUE) at Buy, 'attractive long-term growth story, with first-in-class assets and a validated platform'
Aug 12, 2025 05:47PM
Jul 1, 2025 04:05PM
Jun 24, 2025 04:48PM
May 30, 2025 05:01AM
May 13, 2025 07:02AM
Apr 21, 2025 04:23AM
Apr 15, 2025 04:09AM Citizens JMP Reiterates Market Outperform Rating on Cue Biopharma (CUE)
Apr 14, 2025 05:06PM
Apr 14, 2025 05:00PM
Apr 2, 2025 04:38AM
Nov 15, 2024 08:59AM
Nov 15, 2024 07:07AM
Nov 8, 2024 01:31PM
Sep 27, 2024 06:04AM Cue Biopharma Inc. (CUE) Prices $12M Offering at $0.50/sh
Sep 26, 2024 04:27PM
Sep 9, 2024 08:03AM
Aug 20, 2024 07:32AM
Aug 20, 2024 05:16AM
Aug 19, 2024 04:20PM
Jul 26, 2024 07:44AM
Jul 25, 2024 04:05PM Cue Biopharma (CUE) Announces Strategic Prioritization of Autoimmune Programs

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All